Nucleoside analogues with clinical potential in antivirus chemotherapy. The effect of several thymidine and 2'-deoxycytidine analogue 5'-triphosphates on purified human (alpha, beta) and herpes simplex virus (types 1, 2) DNA polymerases.
D000998:Antiviral Agents / Q000138:chemical synthesis; D004256:DNA Polymerase I / Q000037:antagonists & inhibitors*; D004257:DNA Polymerase II / Q000037:antagonists & inhibitors*; D004279:DNA, Viral / Q000096:biosynthesis; D003845:Deoxycytosine Nucleotides / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D019384:Nucleic Acid Synthesis Inhibitors; D011742:Pyrimidine Nucleotides / Q000138:chemical synthesis / Q000494:pharmacology*; D018139:Simplexvirus / Q000201:enzymology*; D013698:Templates, Genetic; D013942:Thymine Nucleotides / Q000494:pharmacology
D000998:Antiviral Agents; D004279:DNA, Viral; D003845:Deoxycytosine Nucleotides; D019384:Nucleic Acid Synthesis Inhibitors; D011742:Pyrimidine Nucleotides; D013942:Thymine Nucleotides; C024107:2'-deoxycytidine 5'-triphosphate; D004256:DNA Polymerase I; D004257:DNA Polymerase II; C024157:thymidine 5'-triphosphate